chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 27-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 14Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 25 years for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Pulmonary Stenosis as an infant that has been corrected through 2 heart surgeries" (unspecified if ongoing); "2 heart surgeries" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Sudafed, reaction(s): "Allergies: Sudafed"; Zithromax, reaction(s): "Allergies: zithromax"; Fentynal, reaction(s): "Allergies: Fentanyl". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Paxlovid treatment start date: 06Oct2023, treatment stop date: 11Oct2023.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The contributory role of the suspect product to the reported event drug ineffective and COVID-19 cannot be excluded as the efficacy of a drug varies individually and may be affected by different factors including drug potency.
Legs and feet experience swelling and discoloration  Still experiencing to date 3/19/2021
This spontaneous report received from a health care professional concerned a 29 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, expiry: UNKNOWN) dose was not reported, administered on 28-MAR-2022 for prophylactic vaccination. Age at time of vaccination 29 years old. No concomitant medications were reported. On 28-MAR-2022, the patient experienced vaccine was administered to patient without being stored at recommended storage conditions of 2 to 8 celsius. On an unspecified date, the patient experienced product storage error. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the product storage error and vaccine was administered to patient without being stored at recommended storage conditions of 2 to 8 celsius was not reported. This report was non-serious. This case, from the same reporter is linked to 20220505340, 20220505162, 20220505824, 20220505593, 20220505044, 20220505192 and 20220505373.
Increased respirations 44 RR/minute with maintained SpO2 at 90%. Floor nurse had switched resident to higher flow oxygenation at 6L/minute to maintain 90%. Bilateral lung sounds assessed to show no lung sounds in right upper and lower lobe, left lobes remain clear. Pallor evident. Resident is diaphoretic to touch and not responsive to verbal or tactile stimulation including sternal rub. Tachycardia noted at 117 bpm, hypotensive at 89/54.
OB History - G3P2, currently pregnant at 30w4d. EDD 10/8/23.  Received TDAP vaccine 7/20/23 (this pregnancy) and again 8/3/23 in error as the 7/20/23 dose was not seen and patient did not say anything. Pharmacist contacted as well as the manufacturer of the vaccine GlaxoSmithCline. No known side effects or adverse outcomes to patient at this time.
Information has been received from an office manager concerning "a few patients" who were vaccinated with Gardasil. Subsequently the patient experienced dizziness. At the time of the report, the patients outcomes were unknown. No product quality complaint was involved. Additional information has been requested. This is in follow-up to reports previously submitted on 8/14/2007. Initial and follow-up information has been received from an office manager concerning a 12 year old hispanic female stundent with an allergy to amoxicillin, who on 12-JUN-2007 at 14:20 was vaccinated intramusculary in the right arm with a second dose of GARDASIL (lot# 656371/0181U). On 10-APR-2007 the patient was vaccinated with a first dose of GARDASIL (Lot# 656371/0181U). The patient did not experience any problems after the first vaccination. On 12-JUN-2007 at 14:30 the patient slowly became pale and when she tried to get up she slowly went forward and reclined against the wall. The patient experienced syncope that lasted less then a minute (previously reported that the patient experienced dizziness). The patient was treated with oxygen and observed for 45 minutes. On 12-JUN-2007 the patient recovered and left the office walking and well. It was noted that there was no illness at the time of vaccination. No product quality complaint was involved. Additional information is expected.
pt says about a week after taking vax she has joint pain in right elbow and her arm is swollen.  Pt had this same reaction after taking the 1st vaccine on 3/20/21.  She contacted her PCP at that time and was told to use ice packs.  Pts symptoms never went away before getting second dose and now they have gotten worse.  Pt will see her PCP on 5/21/21.
Patient received expired 1st dose of the Moderna vaccine; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired 1st dose of the Moderna vaccine) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired 1st dose of the Moderna vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired 1st dose of the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information was not provided.
This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the third booster dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FH8030) via an unspecified route of administration in the left arm on 21Nov2021 at 17:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fexofenadine/pseudoephedrine hydrochloride (ALLEGRA-D) 24hours, zinc (MANUFACTURER UNKNOWN) and vitamin D NOS (MANUFACTURER UNKNOWN); all for unknown indications from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 22Apr2021 at 13:00 (at the age of 48-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 15May2021 at 13:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient previously received neomycin sulfate (MANUFACTURER UNKNOWN) for an unknown indications on an unknown date and experienced drug allergy. On 22Nov2021 at 05:00, the patient experienced major swelling in the left armpit, pain in jaw and ears, joint pain and pain in the groin area. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events major swelling in the left armpit, pain in jaw and ears, joint pain and pain in the groin area was resolving at the time of this report.
10/11/08 head to toe rash - red bumps - face and head included. 10/10 - 10/13 AM - difficulty swallowing - hoarse. 10/11/08 - Temp - highest 103 - increased sleeping. 10/13 - 10/14 - low grade temp 100-101. 10/13 - vomiting till 10/15. 10/13 - pimple/blister like rash. 10/11 - currently - diarrhea, coughing/stuffy nose.
I had a very deep dry cough that continued on and on making me run out of breath. After 3 days I went to the doctor, and he gave me a prescription for Albuterol Sulfate HSA and to me to take Mucus DR. He also gave me a prescription for Benzonatate. My dry cough changed to a wet cough, or I was coughing up some stuff. It took about a week to see improvement. I still have the cough every once in a while, which is lingering. I don't know if I have recovered yet since I still have this lingering cough. I was also tested for flu
lost sense of taste; Headache; Dizzy; This is a spontaneous report from a Pfizer sponsored program. A female patient reported for herself:  A 40-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER8736) via intramuscularly, in right arm on 29Apr2021 as DOSE 2, SINGLE (at the age of 40-years-old) for COVID-19 immunization. The patient medical history and concomitant medication was not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EW0162), via unspecified route of administration, in right arm on 08Apr2021 as a DOSE 1, SINGLE for covid-19 immunization. On 29Apr2021 the patient experienced headache and dizzy. The patient stated that headache and the dizziness are not there all of the time. They come and go. On an unspecified date of Jun2021 the patient experienced lost sense of taste. On an unspecified date the patient underwent lab tests and procedures twice which included SARS-CoV-1 test (she had Covid) which results in negative (patient went and got the at home Covid test thinking that she had Covid because she lost her sense of taste but said that she has taken them twice and they came back negative for Covid). Outcome for all the reported events was not recovered.  Follow-up attempts are completed. No further information is expected.
Patient received her vaccine with 2 family members in the room who also got the vaccine. Moments after (less than 2 minutes) giving her the vaccine, I was giving another family member the injection and patient asked if she could take her mask off. I turned around and she was very pale. She took her mask off and started slumping in her seat. She was taking deep breaths and reported no difficulties breathing. She then became ill and began gagging, at which point I gave her the trash receptacle to vomit in. I had a technician grab the patient a water and packet of crackers. After half an hour of resting in the chair, monitoring her breathing, blood pressure, heart rate, and getting some food and water into her system, she appeared and reported to feel back to normal. Patient's family member mentioned she had a similar reaction a few weeks ago when getting blood drawn at her doctor's office.
Hair falling (hair loss); Fever; Strong Headache; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair falling (hair loss)), PYREXIA (Fever), HEADACHE (Strong Headache), NAUSEA (Nausea) and CHILLS (Chills) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0371C20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRINE), VITAMINS NOS and BIOTIN for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced ALOPECIA (Hair falling (hair loss)), PYREXIA (Fever), HEADACHE (Strong Headache), NAUSEA (Nausea) and CHILLS (Chills). At the time of the report, ALOPECIA (Hair falling (hair loss)), PYREXIA (Fever), HEADACHE (Strong Headache), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       he has acupuncture therapy coming up.   Reporter did not allow further contact
Patient was noted to have pruritic, red, raised, rash on epigastric region few hours before seen in the office on 5/13/10. While waiting to be seen, the rashes were noted to spread to chest, abdomen, neck & arm, some like mosquito bites, others have fluid like papulo-vesicules. Patient received VARIVAX # 1 on 9/27/2005 & VARIVAX #2 on 10/23/2008.
This spontaneous report was received from a medical assistant concerning an unspecified number of patient of unknown age and gender. The patients' pertinent medical history, concurrent conditions, concomitant therapies, drug reaction or allergies were not reported. The reporter stated that, since 11-JAN-2016, the patients were vaccinated with doses of GARDASIL, lot # K011325, expiration date 08-APR-2017 (dose, dose  number, route and anatomical location were unspecified), that were exposed to 47.9 F during 5 minutes. No adverse experience has been reported.  This is one of several cases received from the same reporter. Additional information has been requested.
Patient got the first dose of Moderna 5 days before he turns 18. No adverse effects or reactions was reported by the patient.
This spontaneous report as received from a licensed practical nurse refers to unspecified number of patients of unknown age. Current conditions and medical history were not reported. On an unknown date in 2014 (reported as since August 2014) the patients were vaccinated with improperly stored PNEUMOVAX 23 (dose, route, lot number and frequency were not reported). Concomitant medications were not reported. No adverse effects were reported. The outcome of the events was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient reports having deltoid muscle pain lingering 4 weeks after vaccination. She states it was sore the day after vaccination and gradually the pain went away, but she still notices it if she moves her muscle in different directions. She reports no shoulder pain/ injury and pointed to deltoid muscle when prompted where it was still hurting. She states it does not impact or limit her daily activities. She has a PCP check up this week and will mention if pain still occurring.
I have the pain and the redness and swelling around the injection site and a little bit further around it; I have the pain and the redness and swelling around the injection site and a little bit further around it; I have the pain and the redness and swelling around the injection site and a little bit further around it; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 2021 (Batch/Lot number: unknown, Expiration Date: 30Nov2021) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetes mellitus" (unspecified if ongoing), notes: Verbatim: Diabetes; "Epilepsy" (unspecified if ongoing), notes: Verbatim: Epilepsy. Concomitant medication(s) included: FLU, administration date 07Oct2021; CLONAZEPAM; KEPPRA XR; VIMPAT. Vaccination history included: Bnt162b2 (Dose: 1st), for COVID-19 immunization; Bnt162b2 (Dose: 2nd), for COVID-19 immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 2021, outcome "unknown" and all described as "I have the pain and the redness and swelling around the injection site and a little bit further around it". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site pain, vaccination site swelling.  Additional information: Consumer stated, she was just trying to report a safety like a safety incident a side effect. she have the pain and the redness and swelling around the injection site and a little bit further around it and a 'tight right arm' (not clear).Lot number: Consumer stated, "301458A can not read hand writing, it looks like 301458A, that make sense. A I think. Consumer stated, Yes she take clonezem. They have no interaction. Keppra 4000 mg a day, 2000 mg twice a day. 'Clonezam' 10 mg twice a day, tablet.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe fatigue the morning following the vaccine (about 22 hours after the shot), which lasted only about an hour. At about 7:00 pm the same day I developed fever, chills, lymph node pain, fatigue, coughing, sneezing. These symptoms lasted about four hours. Four about three days after the shot I had muscle weakness.
complained how sore her arm was; This case was reported by a consumer via (Facebook ) interactive digital media and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The reporter was the patients sister. The patient received dose of shingles vaccine and experienced sore arm . No further information was reported. The follow up was not possible as no contact details were provided. This case has been linked with US2021AMR151907 and US2021AMR151903, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR151907:Same reporter US-GLAXOSMITHKLINE-US2021AMR151903:Same reporter
Woke up with irregular heat beat and just felt like legs and arms were heavy. Put watch on and heart rate at 130 beats/minute. Went to ER and was found to be in atrial fibrillation. Spent 4 hours in the ER.  Heart rate slowed to the 70's-80's but remained in atrial fibrillation.  Lovenox given and a prescription for apixaban 5mg twice daily.
Patient came in on 5/27/20 and said she was still experiencing pain in her left arm where she had the Shingrix vaccination. Patient stated that the reaction started 24 hours admin of the vaccine & that the pain was the same today as it was on 2/16/20 but this is the first time she is reporting it. Patient stated that she had discussed with her physician.
Patient received 2 vaccines on Monday, on Tuesday she developed a rash on her front side and it continued to spread and get worse throughout the week. By Saturday it has spread to her back and looked blistery. it resembled a shingles rash.
This spontaneous prospective pregnancy report as received from a nurse refers to a 33 year old female patient. No information about medical history, concurrent conditions and concomitant medications were reported. On 03-APR-2013 the patient was vaccinated with VARIVAX (Merck) (dose 1). The nurse reported that on 14-AUG-2014 the pregnant patient was vaccinated with VARIVAX (dose 2, subcutaneous, dosage 0.5 ml and lot number K002048, expiration date 10-FEB-2016). Concomitant medications included iron (unspecified), minerals (unspecified), vitamins (unspecified) (also reported as prenatal vitamins). No adverse effect reported. The nurse reported that for gestation or LMP, it was noted that on 17-JUL-2014 the patient had an intrauterine pregnancy of 3 months gestation with approximately calculated date of last menstrual period (LMP) 29-APR-2014 and Estimated date of delivery (EDD) of 03-FEB-2015. Initial exposure to VARIVAX (Merck) was at 15 week(s) of pregnancy. The pregnancy outcome was outcome pending and the fetal outcome is unknown. The outcome of the events reported was unknown. No product quality complaint was involved. Additional information has been requested.
3 Days post vaccination had acute onset of vertigo( dizziness, nausea and vomitting) lasting 3 days. Equilibrium loss still occurring. Was told by Physicians and Specialists that I suffered from Viral Labrynthitis that may be related to Flu vaccine and could take months to years to fully resolve.
Patient Had excessive sleeping (5-7 hours) and screaming for 2-4 hours.
1/26/21 - at 9pm (9hrs after vaccine) he toes, feet and ankles turned "blue" with slight tingling and numbness. The "blue" crept up to her knees at 10pm. Denied pain or tenderness.  1/27/21 - She call public health to report her legs below the knees have been "blue" with slight swelling, tingling and numbness. The tingling is relieved by standing and walking. Denies pain or tenderness. Advised to see her healthcare provider. She sent the health department pictures showing ecchymosis on the lateral side of her ankles and calves.  1/28/21 - TC to patient, she made a doctor's appointment yesterday then canceled it because the "blue" or ecchymosis was better. Denied pain, tenderness, swelling, numbness or tingling.
Pfizer vaccine treatment under Emergency Use Authorization(EUA): Patient administered the Pfizer-biontech Covid 19 vaccine on 1/28/2021 at 15:19 in her LEFT deltoid. Patient reported feeling numbness and tingling to hands, face and leg within 15 minutes of the injection. No dyspnea, nausea, dizziness, abdominal pain, vision changes, or gait abnormality. VS 97.9F, 76, 16, 131/69, pulse ox 100%. ECG sinus rhythm.
A lot of pain in the arm and tiredness the first day and hours later severe allergy with redness and inflammation in the affected area.
My period was delayed a week.  Actually, it first started to spot one day after my expected date of arrival, 1/6/23.  But it stopped after that same Saturday 1/7/23 for one week and then reappeared Friday night, 1/13/23.  My prior vaccinations have similar reactions too.  The second shot of the Pfizer series, and then Moderna booster all changed my period?s length and amount.  It was heavier.  But what bothers me the most was the night sweats from both of those vaccines.  The night sweats lasted between 6-9 months long depending on the manufacturer.  Night sweats are not daily but randomly during the month, mostly during my period, but not always.  I have yet to observe the night sweats from the Pfizer bivalent booster.
As soon as I got home from work on the day of receiving my vaccine (at work), I was able to take off my sweater and see my arm in the mirror. I noticed that the landmarking for the vaccine was incorrect (much higher and more posterior) than it should have been. The band-aid was also saturated with blood, a first for me after any vaccine. Upon analgesic usage for muscular-related shoulder pain from vaccine in the first 48 hours of vaccine administration, there was pain within the shoulder joint with range of motion activities and at rest that were unaffected by analgesic usage. As the muscle-related shoulder pain (the sore arm that is very common and lasts 48 hours max) from vaccine administration went away, the joint pain and range of motion issues remained. Today, it has been 18 days since vaccination. I experience pain at rest in my shoulder joint and with movement. Analgesics are not completely effective.  I brought this issue up at a routine visit with my chiropractor 10/22  and he was able to re-set my collar bone on the right side (related to the internal injury), and do some range of motion and therapeutic massage at the area. His opinion is that this injury is presenting as a strain despite the lack of mechanical insult on my part. There has been no relief after this intervention, and it is worse today 10/23.